High lipoprotein(a) concentrations are associated with impaired endothelial function in children

Jouni Lapinleimu1, Olli T Raitakari2, Helena Lapinleimu3

  • 1Department of Medicine, University of Turku, Turku, Finland; Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Division of Medicine, TYKS Salo Hospital, Salo, Finland.

The Journal of Pediatrics
|February 10, 2015
PubMed

Insights

Familial high lipoprotein(a) (Lp(a)) is linked to reduced endothelial function in children. Early lifestyle interventions may help mitigate this association, promoting better cardiovascular health.

Area of Science:

  • Cardiovascular Research
  • Pediatric Health
  • Endocrinology

Background:

  • Lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease.
  • Familial hyperlipoproteinemia(a) can predispose children to early cardiovascular risks.
  • Understanding Lp(a)'s impact on pediatric endothelial function is crucial for early intervention.

Purpose of the Study:

  • To investigate the relationship between elevated familial lipoprotein(a) (Lp(a)) levels and endothelial function in children.
  • To assess if early lifestyle interventions can modify the impact of high Lp(a) on vascular health.
  • To analyze flow-mediated dilation (FMD) as a marker of endothelial function in relation to Lp(a) concentrations.

Main Methods:

  • A randomized controlled trial involving 1062 families, with an intervention group receiving dietary counseling.
  • Measurement of children's Lp(a) and lipid levels, with endothelial function assessed via brachial artery flow-mediated dilation (FMD) at age 11.
  • Linear regression analyses were used to examine the association between FMD and Lp(a) in control and intervention groups, specifically in familial risk children.

Main Results:

  • A significant inverse association was observed between Lp(a) concentration and FMD in control children and familial risk children.
  • This association between Lp(a) and attenuated endothelial function was not significant in the intervention group.
  • Children with very high Lp(a) (>500 mg/L) in the intervention group showed no attenuation in FMD, suggesting a protective effect of the intervention.

Conclusions:

  • Familial high lipoprotein(a) concentration is associated with impaired endothelial function in children.
  • Early lifestyle intervention appears to mitigate the negative effects of high Lp(a) on endothelial function.
  • These findings highlight the importance of early intervention for children with familial hyperlipoproteinemia(a).
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
877
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
646
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
7.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613